New research led by scientists at La Jolla Institute for Immunology reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component of Ebola virus therapeutics.

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which ...

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb ...

A study published in December by Duke professor Rohit Singh and his team proposes a new computational model called antibody ...